Company
gritstoneoncology
Pursuing More Potent and Durable Immune Responses for Cancer
Also known as gritstone-oncology, Nexoplex Bio, Nexoplex bio, LLC
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Nexoplex bio, LLC
- gritstoneoncology.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Nexoplex's goal is to develop groundbreaking immunotherapies for cancer. Our approach focuses on the use of multi-specific antibodies to bind to a tumor target and generate a therapeutic immune response by leveraging the natural power of a patient’s immune system to recognize and destroy tumor cells.
Loading relationship preview